258 related articles for article (PubMed ID: 26599245)
1. Effect of a Strict 'No-Talking' Policy During Intravitreal Injection on Post-Injection Endophthalmitis.
Garg SJ; Dollin M; Hsu J; Storey P; Vander JF
Ophthalmic Surg Lasers Imaging Retina; 2015; 46(10):1028-34. PubMed ID: 26599245
[TBL] [Abstract][Full Text] [Related]
2. Comparison of endophthalmitis rates following intravitreal injection of compounded bevacizumab, ranibizumab, and aflibercept.
Forooghian F; Albiani DA; Kirker AW; Merkur AB
Can J Ophthalmol; 2017 Dec; 52(6):616-619. PubMed ID: 29217032
[TBL] [Abstract][Full Text] [Related]
3. Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept.
Rayess N; Rahimy E; Storey P; Shah CP; Wolfe JD; Chen E; DeCroos FC; Garg SJ; Hsu J
Am J Ophthalmol; 2016 May; 165():88-93. PubMed ID: 26944277
[TBL] [Abstract][Full Text] [Related]
4. Current Infectious Endophthalmitis Rates After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents and Outcomes of Treatment.
Gregori NZ; Flynn HW; Schwartz SG; Rosenfeld PJ; Vaziri K; Moshfeghi AA; Fortun JA; Kovach JL; Dubovy SR; Albini TA; Davis JL; Berrocal AM; Smiddy WE
Ophthalmic Surg Lasers Imaging Retina; 2015 Jun; 46(6):643-8. PubMed ID: 26114845
[TBL] [Abstract][Full Text] [Related]
5. Incidence of presumed endophthalmitis after intravitreal injection performed in the operating room: a retrospective multicenter study.
Casparis H; Wolfensberger TJ; Becker M; Eich G; Graf N; Ambresin A; Mantel I; Michels S
Retina; 2014 Jan; 34(1):12-7. PubMed ID: 23945639
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies.
McCannel CA
Retina; 2011 Apr; 31(4):654-61. PubMed ID: 21330939
[TBL] [Abstract][Full Text] [Related]
7. The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection.
Storey P; Dollin M; Pitcher J; Reddy S; Vojtko J; Vander J; Hsu J; Garg SJ;
Ophthalmology; 2014 Jan; 121(1):283-289. PubMed ID: 24144453
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.
Inoue M; Kobayakawa S; Sotozono C; Komori H; Tanaka K; Suda Y; Matsushima H; Kinoshita S; Senoo T; Tochikubo T; Kadonosono K
Ophthalmologica; 2011; 226(3):145-50. PubMed ID: 21811052
[TBL] [Abstract][Full Text] [Related]
9. The effect of prophylactic topical antibiotics on bacterial resistance patterns in endophthalmitis following intravitreal injection.
Storey P; Dollin M; Rayess N; Pitcher J; Reddy S; Vander J; Hsu J; Garg S;
Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):235-42. PubMed ID: 25940556
[TBL] [Abstract][Full Text] [Related]
10. Aqueous Chlorhexidine for Intravitreal Injection Antisepsis: A Case Series and Review of the Literature.
Merani R; McPherson ZE; Luckie AP; Gilhotra JS; Runciman J; Durkin S; Muecke J; Donaldson M; Aralar A; Rao A; Davies PE
Ophthalmology; 2016 Dec; 123(12):2588-2594. PubMed ID: 27720552
[TBL] [Abstract][Full Text] [Related]
11. MICROBIAL SPECTRUM AND OUTCOMES OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION VERSUS PARS PLANA VITRECTOMY.
Garg SJ; Dollin M; Storey P; Pitcher JD; Fang-Yen NH; Vander J; Hsu J;
Retina; 2016 Feb; 36(2):351-9. PubMed ID: 26200514
[TBL] [Abstract][Full Text] [Related]
12. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
[TBL] [Abstract][Full Text] [Related]
13. Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome.
Dossarps D; Bron AM; Koehrer P; Aho-Glélé LS; Creuzot-Garcher C;
Am J Ophthalmol; 2015 Jul; 160(1):17-25.e1. PubMed ID: 25892127
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab.
Storey PP; Tauqeer Z; Yonekawa Y; Todorich B; Wolfe JD; Shah SP; Shah AR; Koto T; Abbey AM; Morizane Y; Sharma P; Wood EH; Morizane-Hosokawa M; Pendri P; Pancholy M; Harkey S; Jeng-Miller KW; Obeid A; Borkar DS; Chen E; Williams P; Okada AA; Inoue M; Shiraga F; Hirakata A; Shah CP; Prenner J; Garg S;
Am J Ophthalmol; 2019 Mar; 199():200-208. PubMed ID: 30552891
[TBL] [Abstract][Full Text] [Related]
15. Acute endophthalmitis after intravitreal injection and preventive effect of preoperative topical antibiotics.
Park Y; Kim KS; Park YH
J Ocul Pharmacol Ther; 2013 Dec; 29(10):900-5. PubMed ID: 24067061
[TBL] [Abstract][Full Text] [Related]
16. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab.
Fintak DR; Shah GK; Blinder KJ; Regillo CD; Pollack J; Heier JS; Hollands H; Sharma S
Retina; 2008; 28(10):1395-9. PubMed ID: 18827737
[TBL] [Abstract][Full Text] [Related]
17. Endophthalmitis Rates after Bilateral Same-Day Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
Borkar DS; Obeid A; Su DC; Storey PP; Gao X; Regillo CD; Kaiser RS; Garg SJ; Hsu J;
Am J Ophthalmol; 2018 Oct; 194():1-6. PubMed ID: 29981738
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates.
Englander M; Chen TC; Paschalis EI; Miller JW; Kim IK
Br J Ophthalmol; 2013 Apr; 97(4):460-5. PubMed ID: 23390167
[TBL] [Abstract][Full Text] [Related]
19. ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION: Role of Prophylactic Topical Ophthalmic Antibiotics.
Li AL; Wykoff CC; Wang R; Chen E; Benz MS; Fish RH; Wong TP; Major JC; Brown DM; Schefler AC; Kim RY; OʼMalley RE
Retina; 2016 Jul; 36(7):1349-56. PubMed ID: 26655622
[TBL] [Abstract][Full Text] [Related]
20. Incidence of Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor: Experience in Saudi Arabia.
Al-Rashaed S; Alsulaiman SM; Alrushood AA; Almasaud J; Arevalo JF
Middle East Afr J Ophthalmol; 2016; 23(1):60-3. PubMed ID: 26957840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]